Implementation and Evaluation of Tailored Interventions to Increase MMR and/or HPV Vaccine
NCT ID: NCT06361628
Last Updated: 2024-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
1000 participants
INTERVENTIONAL
2024-05-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main research question is: to what extent is the multicomponent tailored intervention effective to increase MMR/HPV intention and vaccine uptake in the target population in Greece, Netherlands, Poland and Slovakia?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Giving Immunizations Through Vaccine Education
NCT01159093
Leveraging Social Innovation and Community-Engagement to Reduce Disparities in Outbreak Control Outcomes
NCT05123729
Racial Disparities in Pneumococcal Vaccination in Managed Care
NCT00229762
Community Care Intervention to Decrease COVID-19 Vaccination Inequities
NCT06156254
Advancing Vaccine Equity Through Understanding Vaccine Hesitancy, Barriers, and Trust
NCT05537714
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A prospective multicomponent intervention study will be performed between 1st of April 2024 and 31st of July 2025 that will be evaluated using a pre and post design as well as a participatory approach during the implementation. As part of the multicomponent intervention a preparatory phase is taken place before this period of time. The multicomponent intervention consists of training of health promotors and healthcare professionals, and of educational sessions to community members and navigation. The educational sessions will be offered at suitable and accessible locations for the target population.
The five communities targeted in are the following:
1. The migrant community in Greece (HPV and MMR)
2. Turkish and Moroccan women in the Netherlands (HPV)
3. The Ukrainian community in Poland (HPV and MMR)
4. The Roma community in Slovakia (HPV)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Educational sessions delivered by health promotors in Greece
In this approach, medical professionals and health promoters-trusted members of the community-will educate refugee and migrant parents. The focus is on enhancing awareness of HPV/MMR and fostering a greater willingness to vaccinate their children/adolescents. Multicultural schools and migrant associations are the locations where the educational sessions will be provided.
multicomponent intervention on vaccination awareness
Educational sessions to create awareness on HPV and MMR (were addressed) vaccination that is culturally sensitive health information and provided in an easily understandable manner by trained health promoters (and healthcare professionals) to underserved communities. Support for navigation and access to vaccines.
Educational sessions delivered by health promotors and healthcare professionals in the Netherlands
Trusted community health members will be trained and will act as health promotors in the intervention. Together with health care professionals they will offer educational sessions on HPV vaccination at locations close to where people live (in the neighborhoods) and locations communities are familiar with, such as community centers, schools, health centers, religious places or offices of foundations/non-governmental organizations. Together with local stakeholders it will be verified that locations are also acceptable for the target communities. A navigation component is also included and participants will be contacted 1 week and 3 months after the educational sessions and reminded to get vaccinated and will be asked if they still have questions or need help to find their way to get vaccinated.
multicomponent intervention on vaccination awareness
Educational sessions to create awareness on HPV and MMR (were addressed) vaccination that is culturally sensitive health information and provided in an easily understandable manner by trained health promoters (and healthcare professionals) to underserved communities. Support for navigation and access to vaccines.
Educational sessions delivered by health promotors in Poland
This intervention is based on the principle of face-to-face and online health education, where Ukrainian parents are educated by general practitioners to raise HPV/MMR awareness and increase willingness to child/adolescent vaccination.
multicomponent intervention on vaccination awareness
Educational sessions to create awareness on HPV and MMR (were addressed) vaccination that is culturally sensitive health information and provided in an easily understandable manner by trained health promoters (and healthcare professionals) to underserved communities. Support for navigation and access to vaccines.
Educational sessions delivered by health promotors in Slovakia
Roma health mediators will be trained on HPV vaccination and thereafter will offer educational sessions to the underserved communities. Educational sessions take place at either municipalities, schools, community centers, local health care providers and public health authorities.
multicomponent intervention on vaccination awareness
Educational sessions to create awareness on HPV and MMR (were addressed) vaccination that is culturally sensitive health information and provided in an easily understandable manner by trained health promoters (and healthcare professionals) to underserved communities. Support for navigation and access to vaccines.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
multicomponent intervention on vaccination awareness
Educational sessions to create awareness on HPV and MMR (were addressed) vaccination that is culturally sensitive health information and provided in an easily understandable manner by trained health promoters (and healthcare professionals) to underserved communities. Support for navigation and access to vaccines.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
12 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prolepsis Institute for Preventive, Environmental and Occupational Medicine
OTHER
University in Zielona Góra
OTHER
Pavol Jozef Safarik University
OTHER
University Medical Center Groningen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nikole Papaevgeniou, PhD
Role: PRINCIPAL_INVESTIGATOR
Prolepsis Institute for Preventive, Environmental and Occupational Medicine
Daniela Fiľakovská, PhD
Role: PRINCIPAL_INVESTIGATOR
UPJS
Maria Ganczak, MD PhD
Role: PRINCIPAL_INVESTIGATOR
University Zielona Gora
Michael Edelstein, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Bar Ilan University
Cornelis Boersma, PhD
Role: PRINCIPAL_INVESTIGATOR
UMCG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prolepsis
Athens, Athene, Greece
University Medical Center Groningen
Groningen, , Netherlands
University of Zielona Gora
Zielona Góra, Lubusz Voivodeship, Poland
PJ Šafárik University
Košice, Košice Region, Slovakia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIVER-EU WP4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.